Cargando…
Mechanism through Which Retrocyclin Targets Flavivirus Multiplication
Currently, there are no approved drugs for the treatment of flavivirus infection. Accordingly, we tested the inhibitory effects of the novel θ-defensin retrocyclin-101 (RC-101) against flavivirus infection and investigated the mechanism underlying the potential inhibitory effects. First, RC-101 robu...
Autores principales: | Jia, Xiaoying, Guo, Jiao, Yuan, Weirong, Sun, Lingling, Liu, Yang, Zhou, Minmin, Xiao, Gengfu, Lu, Wuyuan, Garzino-Demo, Alfredo, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274595/ https://www.ncbi.nlm.nih.gov/pubmed/33980602 http://dx.doi.org/10.1128/JVI.00560-21 |
Ejemplares similares
-
Screening of Botanical Drugs against Lassa Virus Entry
por: Liu, Yang, et al.
Publicado: (2021) -
Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library
por: Wang, Peilin, et al.
Publicado: (2018) -
Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection
por: Wang, Shaobo, et al.
Publicado: (2017) -
RNA Interference Screening Reveals Requirement for Platelet-Derived Growth Factor Receptor Beta in Japanese Encephalitis Virus Infection
por: Zhou, Minmin, et al.
Publicado: (2021) -
Identification of tanshinone I as cap-dependent endonuclease inhibitor with broad-spectrum antiviral effect
por: He, Xiaoxue, et al.
Publicado: (2023)